Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Notal Vision
AddedFeb 15, 2024
UpdatedJun 18, 2026
Notal Vision

Notal Vision

Series D

Virginia-based Notal Vision provides home diagnostic services for improved eye disease management.

HQ
Manassas, VA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Founded in Manassas, Virginia, Notal Vision is a digital health company dedicated to extending eye disease management from the clinic to the home. Their core mission is to improve vision outcomes by addressing unmet diagnostic needs in ophthalmology through home-based, patient-operated diagnostics and AI-enabled data analysis. Notal Vision offers innovative solutions for age-related macular degeneration (AMD) management, allowing for more precise and timely interventions.

Notal Vision has garnered attention for its pioneering approach and has been supported by notable investors and industry experts. The company’s key achievements include the successful implementation of home diagnostic services that have significantly impacted patient care and outcomes. By integrating advanced technology with patient-centric care, Notal Vision has made a substantial impact on the field of ophthalmology, setting new standards for remote eye disease management.

Notal Vision - Similar Companies

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Insight Optics logo

Insight Optics

io.care

Eyenuk logo

Eyenuk

eyenuk.com

Aeye Health logo

Aeye Health

aeyehealth.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Vital Art and Science logo

Vital Art and Science

myvisiontrack.com

Eyedaptic logo

Eyedaptic

eyedaptic.com

VisionQuest Biomedical logo

VisionQuest Biomedical

Quadrant Eye logo

Quadrant Eye

Ocular Diagnostics logo

Ocular Diagnostics

Luminopia logo

Luminopia

luminopia.com

Optain logo

Optain

optainhealth.com

Retina-Ai Health logo

Retina-Ai Health

Vitazi.ai logo

Vitazi.ai

vitazi.ai

Vitrea Health logo

Vitrea Health

vitreahealth.com

Notal Vision - Quick Facts

Who are Notal Vision's competitors?

Companies similar to Notal Vision include NeuroVision Imaging, Insight Optics, Eyenuk and Aeye Health.

When was Notal Vision founded?

Notal Vision was founded in 2000.

Where is Notal Vision's headquarters located?

Notal Vision's headquarters is located in Manassas, VA, US.

When was Notal Vision's last funding round?

Notal Vision's most recent funding round was for $60M (USD) in June 2021.

How much has Notal Vision raised to-date?

As of Jun 1, 2021, Notal Vision has raised a total of $85M (USD).

How many employees does Notal Vision have?

Notal Vision has 100 employees as of Feb 4, 2024.

Notal Vision - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Diagnostic Services
Tags
  • Healthtech
  • TeleMedicine
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 8 more industry codes
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus